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Macaranga known locally as mahang-mahangan has 
uniquely ecological function, and also became a part of 
traditional medicine in Indonesia. Macaranga genus also known 
as a sources of terpenoid and phenolic (flavonoid) compounds 
which have biological activity as antioxidant and anticancer 
(cytotoxicity).There are few phytochemical investigations have 
been done on M. gigantifolia species. As a part of our continuing 
research of isolation anticancer compound from natural product, 
a geranylated flavonoid compound (macarangin) has been 
isolated from ethyl acetate fraction of Macaranga gigantifolia 
leaves using chromatography methods. The isolated compund 
(isolat MG) was elucidated to gain the chemical structure based 
on spectroscopic data (LC-MS and FT-NMR). Cytotoxicity test of 
this compound was tested against MCF 7 cell lines, showed that 
macarangin has a potential activity with IC50 value 
119.12μg/mL.   
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INTRODUCTION 
Macaranga (Euphorbiaceae), known 
locally as mahang-mahangan has uniquely 
ecological function, and also became a part of 
traditional medicine in Indonesia such as for 
diarrhea, wound and cough (Heyne, 1987). 
There are more than 308 species of Macaranga, 
wide-spread from Africa and west region of 
Madagascar until tropical region of Asia, North 
Australia and east region of Pacific Islands 
(Blattner, 2001). Macaranga genus also known as 
a sources of terpenoid (Hui, 1971)] and 
phenolic (flavonoid) (Jang, 2002; Schutz, 1995; 
Sutthivaiyakit, 2002; Yoder, 2007) compounds 
which have biological activity as antioxidant 
(Phommart, 2005) and anticancer (cytotoxicity) 
(Yoder, 2007). Macarangin, a geranylated 
flavonoid compound is one of the flavonoid 
typical compounds contained in Macaranga 
genus, and have been isolated from M. vedeliana 
(Hnawia, 1990) and M. denticulate (Sutthivaiyakit, 
2002). Scopoletin is one of the secondary 
metabolite compounds was isolated from M. 
gigantifolia (Darmawan, 2012). There are few 
phytochemical investigations have been done 
on M. gigantifolia species. This study reports 
about the isolation and structure elucidation of 
macarangin from the ethyl acetate fraction of 
methanolic extract of M. gigantifolia leaves. This 
is the first reports about macarangin compound 
isolated from M. gigantifolia. 
 
MATERIAL AND METHODS 
M. gigantifolia leaves collected from 
Mekongga forest region, Kolaka District, 
Southeast Sulawesi - Indonesia in March 2013 
and identified by Mr. Ismail Rachman from 




NMR spectra were recorded on a JEOL 
JNM-ECA 500 Spectrometer with TMS as an 
internal standard, and ESI-MS was performed 
on Mariner Shimadzu ESI system. 
 
Procedure  
Extraction and isolation 
Two hundred milligram ethyl acetate 
fraction obtained from methanolic extract              
of M. gigantifolia leaves was dissolved in acetone, 
and chromatographed with chromatotron 
(centrifugal thin-layer chromatograph) using 
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gradient system solvent n-hexane – ethyl acetate 
(8:2 to 6:4) successively  to obtain 12 fractions 
(F1-F12). F12 further separated by chromato-
tron using n-hexane-ethyl acetate (6:4) to afford 
8 sub-fractions (FS-1 to FS-8) based on the 
TLC (Silica Gel GF 254, Merck) data. FS-6 
further purified by preparative thin layer 
chromatography (TLC-P) to obtain Isolate MG.  
 
Chemical compound characterization 
Isolate MG characterized based on 
spectroscopic data obtained from FT-NMR and LC-
MS analysis. FT-NMR and LC-MS analysis 
performed with JEOL JNM-ECA 500 MHz and 
Mariner Shimadzu ESI system. 
 
Cytotoxicity test in vitro with Methyl 
Thyazole Tetrazolium (MTT) Assay 
Isolate MG was tested in vitro for its 
cytotoxicity against MCF-7 cell line. MCF-7 
cells growth inhibition by Isolat MG was 
analyzed 3-(4,5-dimethylthyazole-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) assay 
reported by Jin (2010) and Yunianto (2012). 
MCF-7 cells were seeded in 96 well plates and 
incubated with MTT (5mg/mL) for 4h. Cells 
further solubilized by added 100µL of DMSO. 
Absorbance was read at 570nm. Cell viability in 
treated cells was expressed as the amount of 
dye reduction relative compared to untreated 
control cells. The wells which contained only 
medium and 10mL of MTT were used as 
blanks for the plate reader. 
 
RESULTS AND DISCUSSION 
Chemical compound characterization 
Isolate MG, a yellowish brown paste 
obtained from two step chromatography 
process using chromatotron with n-hexane:ethyl 
acetate as solvent system, gave a molecular ion 
[M+H] m/z 423.20 in ESI-MS, which mean 
that [M+] is m/z 422.20.  
FT-NMR: Isolate MG, a yellowish 
brown paste. 1H-NMR (in acetone-d6, 500 
MHz) (δ ppm, ΣH, J Hz) 1.54 (s, 3H, H-9”), 
1.59 (s, 3H, H-10”), 1.79 (s, 3H, H-8”), 1.96 (dd, 
1H, 8.4, H-4”), 2.07 (dd, 2H, 8.4/7.1, H-5”), 
3.37 (d, 2H, 7.1, H-1”), 5.07 (t, 1H, 7.1, H-6”), 
5.30 (t, 1H, 7.1, H-2”), 6.62 (s, 2H, H-8), 7.01 
(d, 2H, 9.05, H-3’/H-5’), 8.13 (d, 2H, 8.4, H-
2’/H-6’), 12.42 (s, 1H, -OH). 13C-NMR (in 
acetone-d6, 125 Hz) (δ ppm) 16.32 (C-8”), 
17.73 (C-9”), 25.87 (C-10”), 21.99 (C-1”), 27.44  
(C-5”), 40.57 (C-4”), 93.97 (C-8),  103.97 (C-10), 
111.86 (C-6), 116.36 (C-3’/5’), 123.22 (C-2”), 
123.48 (C-1’), 125.19 (C-6”), 130.43 (C-2’/6’), 
131.65 (C-7”), 135.37 (C-3”), 136.62 (C-3), 
146.69 (C-2), 155.73 (C-9), 158.97 (C-5), 160.15 
(C-4’), 163.10 (C-7), 176.58 (C-4, -C=O).  
Based on the 1H-NMR data showed that 
Isolate MG has 5 aromatic proton at δ 6.62, 
7.01 (2H) and 8.13 (2H), 2 methine triplet 
signals at δ 5.07 and 5.30 typical for prenyl 
group, 1 hydroxyl group at δ 12.42, 3 methyl 
singlet at δ 16.26, 17.85 and 25.75, 3 methylene 
signals at δ 1.97, 2.07, and 3.37. 13C-NMR data 
showed 25 carbon atoms consist of 5 aromatic 
methine signal at δ 93.9, 116.4 (2C), and 130.4 
(2C), 11 quaternary carbon atoms at δ 103.97, 
111.86, 123.48, 131.65, 135.37, 136.62, 146.69, 
155.73, 158.97, 160.15, and 163.1, 1 carbonyl 
atom at δ 176.58. Proton signal at δ 7.01 (2H) 
and 8.13 (2H) which have correlation in         
ortho position indicates that this 4 proton 
located in the same aromatic ring. Proton 
aromatic  (δ 6.62) indicates that there is another 
aromatic ring. 2 typical prenyl group methine 
correlated with only 3 methyl signals and 3 
methyene signals indicates that the constituent 
is geranyl.  
From the NMR data (1H- and 13C-NMR) 
indicates that Isolat MG is a geranylated 
flavonoid compound. Data HMBC-NMR 
showed that methylene group at δ 3.37 (H-1”) 
correlated with three ring A carbon atom C-5, 
C-6, and C-7, it means geranyl substituent 
attached to the flavonoid aglycone through A 
ring (Figure 1.). 
Based on NMR data, supported by LC-
MS data and reference comparative (Table I.), 
Isolat MG was identified as macarangin 
(Figure 2) (Hnawia, 1990). This is the first 
report about macarangin content in Macaranga 
gigantifolia. 
 
Cytotoxicity test in vitro with Methyl 
Thyazole Tetrazolium (MTT) Assay.  
Cytotoxicity test (Table II) of Isolat MG 
was carried out at 100 ppm concentration using 
MTT viability test against MCF-7 cells (breast 
cancer cell) showed that Isolat MG could 
inhibit the growth of MCF-7 cell with IC50 
value 119.12μg/mL (Figure 3). It means that 
Isolat MG has medium potential activity as 
breast cancer inhibitor. 
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Table I. 1H- and 13C-NMR data of Isolate MG and Macarangin 
 
No. 
Isolat MG Macarangin (Hnawia, 1990) 
δH (mult., ΣH, J in Hz) δC δH (mult., ΣH, J in Hz) δC 
2  146.69  146.00 
3  136.62  135.61 
4  176.58  177.25 
5  158.97  160.35 
6  111.86  112.32 
7  163.10  163.10 
8 6.62 (s, 1H) 93.97 6.43 (s, 1H) 93.70 
9  155.73  156.13 
10  103.97  104.28 
1’  123.48  123.90 
2’/6’ 8.13 (d, 2H, 8.4) 130.43 8.10 (d, 2H, 8) 130.55 
3’/5’ 7.01 (d, 2H, 9.0) 116.36 6.90 (d, 2H, 8) 116.26 
4’  160.15  159.04 
1” 3.37 (d, 2H 7.15) 21.99 3.30 (d, 2H, 7) 22.11 
2” 5.30 (t, 1H, 7.15) 123.22 5.25 (t, 1H, 7) 123.64 
3”  135.37  136.97 
4” 1.79 (s, 3H) 16.32 1.80 (s, 3H) 16.26 
5” 1.97 (dd, 2H, 8.4) 40.57 2.00 40.64 
6” 2.97 (dd, 2H, 8.4/7.15) 27.44 3.00 27.72 
7” 5.07 (t, 1H, 7.15) 125.19 5.08 (t, 1H, 7) 125.46 
8”  131.65  131.95 
9” 1.54 (s, 3H) 17.73 1.57 (s, 3H) 17.85 
































































































Figure 1. HMQC- and HMBC-NMR correlation of Isolate MG compound 
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CONCLUSION 
A geranylated flavonoid compound, 
macarangin (Isolat MG) has been isolated 
from the ethyl acetate fraction of Macaranga 
gigantifolia leaves. The cytotoxicity assay against 
MCF-7 cell lines showed that Macarangin has 
potential activity as breast cancer inhibitor with 
IC50 value 119.12μg/mL.  
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Figure 2. Chemical structure of macarangin 
 
Table II. Anticancer activity of macarangin against MCF-7 cell lines 
 










Figure 3. Anticancer activity of macarangin against MCF-7 cell lines 
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